EVOTEC WKN: 566480 ISIN: DE0005664809 Forum: Aktien Thema: Hauptdiskussion

Insolvenz möglich?

Kann die Bude nicht einfach jemand kaufen

Die Bude macht jetzt Verluste: 🔥 Evotec senkt wegen erwarteter Umsatzverschiebungen und geringerer Erlöserwartungen seine Jahresziele 2026 deutlich. Das Unternehmen stellt nun 570–610 Mio Euro Umsatz (zuvor 700–780 Mio) und ein bereinigtes EBITDA von minus 70 bis minus 105 Mio Euro (zuvor 0 bis 40 Mio) in Aussicht.

Was für ein rotz

Fangen wir halt wieder von vorne an.

Morgen minus 30%

Ich habe Glück im Pech gehabt. Am Hoch mit größeren Paket raus. Klein nachgelegt und ausgenockt. Waren nur ein paar Hunderter. Trotzdem Hammer.

Wtf😯

Sauber

Bei 3.75 steige ich mal ein, mit der 1 Tranche

EQS-Adhoc: Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook EQS-Ad-hoc: EVOTEC SE / Key word(s): Forecast / Full year/Results / Half year Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook 13-Jul-2026 / 21:17 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this announcement. Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014 Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook Hamburg, Germany – Evotec SE (NASDAQ: EVO; Frankfurt Prime Standard: EVT) today announced preliminary unaudited financial results for the second quarter and first half of 2026 and updated its full-year 2026 outlook. Full financial results for the second quarter and first half of 2026 will be published on August 13, 2026, as scheduled. Based on preliminary figures, Evotec expects Group revenues for the first half of 2026 of approximately €300.1 million and adjusted Group EBITDA of approximately -€42.7 million. As of June 30, 2026, liquidity is expected to amount to approximately €465.6 million. Reflecting these factors, Evotec now expects full-year 2026 Group revenues of approximately €570 to 610 million (€595 to 635 million CER) and adjusted Group EBITDA of approximately -€70 to -105 million (-€60 to -90 million CER). This compares with previous guidance of €700 to 780 million (€730 to 810 million CER) for Group revenues and €0 to 40 million (€10 to 50 million CER) for adjusted Group EBITDA. – End of the ad hoc release – Contact: Dr. Sarah Fakih, EVP Head of Global Communications and Investor Relations, Evotec SE, Manfred Eigen Campus, Essener Bogen 7, 22419 Hamburg, Germany, Phone: +49 (0) 151 7068 8784 (m), sarah.fakih@evotec.com End of Inside Information 13-Jul-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. View original content: EQS News Language: English Company: Evotec SE Manfred Eigen Campus / Essener Bogen 7 22419 Hamburg Germany Phone: +49 (0)40 560 81-0 E-mail: info@evotec.com Internet: www.evotec.com ISIN: DE0005664809 WKN: 566480 Indices: SDAX, TecDAX Listed: Regulated Market in Frankfurt (Prime Standard), Tradegate BSX; Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart; Nasdaq EQS News ID: 2365126 End of Announcement EQS News Service 2365126 13-Jul-2026 CET/CEST

Die Zahlen sind grauenvoll

Tolle News.

High Performance Aktie 🙈

Mal sehen wie es bei der Low Performer Aktie weiter geht 🤣

Mal nicht übertreiben, gerade mal zurück auf 5 gekommen. News gibt es weiter keine …